down arrow

New Journey Health Technology Group Co., Ltd.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE1000009R5
  • SHE: 002219
CNY
2.16
-0.02 (-0.92%)

Sep 22

SHE

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
New Journey Health Technology Group Co., Ltd.

Why is New Journey Health Technology Group Co., Ltd. ?

1
The company is Net-Debt Free
  • Poor long term growth as Net Sales has grown by an annual rate of 0.17% and Operating profit at 3.12% over the last 5 years
  • The company is Net-Debt Free
  • The company has been able to generate a Return on Equity (avg) of 3.44% signifying low profitability per unit of shareholders funds
2
Poor long term growth as Net Sales has grown by an annual rate of 0.17% and Operating profit at 3.12% over the last 5 years
3
The company has declared Negative results for the last 4 consecutive quarters
  • NET PROFIT(9M) At CNY 44.1 MM has Grown at -45.02%
  • NET SALES(HY) At CNY 1,516.62 MM has Grown at -20.78%
  • INVENTORY TURNOVER RATIO(HY) Lowest at 10.82 times
4
With ROE of 1.49%, it has a very expensive valuation with a 3.52 Price to Book Value
  • Over the past year, while the stock has generated a return of -16.82%, its profits have fallen by -75.9%
5
Consistent Underperformance against the benchmark over the last 3 years
  • Along with generating -16.82% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in each of the last 3 annual periods
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is New Journey Health Technology Group Co., Ltd. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
New Journey Health Technology Group Co., Ltd.
-7.69%
-0.33
40.47%
China Shanghai Composite
3.23%
1.20
14.07%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
0.17%
EBIT Growth (5y)
3.12%
EBIT to Interest (avg)
1.30
Debt to EBITDA (avg)
3.17
Net Debt to Equity (avg)
0.74
Sales to Capital Employed (avg)
0.88
Tax Ratio
60.50%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
5.21%
ROE (avg)
3.44%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
201
Industry P/E
Price to Book Value
3.01
EV to EBIT
38.01
EV to EBITDA
20.54
EV to Capital Employed
2.12
EV to Sales
2.51
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
5.59%
ROE (Latest)
1.49%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bearish
Moving Averages
Bearish (Daily)
KST
Bullish
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

4What is working for the Company
PRE-TAX PROFIT(Q)

At CNY 13.94 MM has Grown at 321.71%

NET PROFIT(9M)

Higher at CNY 78.68 MM

-13What is not working for the Company
OPERATING CASH FLOW(Y)

Lowest at CNY 218.93 MM

DEBTORS TURNOVER RATIO(HY)

Lowest at 2.15 times

DEBT-EQUITY RATIO (HY)

Highest at 112.43 %

INVENTORY TURNOVER RATIO(HY)

Lowest at 11.7 times

NET SALES(Q)

Fallen at -13.13%

Here's what is working for New Journey Health Technology Group Co., Ltd.

Pre-Tax Profit
At CNY 13.94 MM has Grown at 321.71%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (CNY MM)

Net Profit
Higher at CNY 78.68 MM
than preceding 12 month period ended Jun 2026
MOJO Watch
In the nine month period the company has already crossed sales of the previous twelve months

Net Profit (CNY MM)

Here's what is not working for New Journey Health Technology Group Co., Ltd.

Debtors Turnover Ratio
Lowest at 2.15 times and Fallen
In each half year in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Operating Cash Flow
Lowest at CNY 218.93 MM
in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Net Sales
Fallen at -13.13%
Year on Year (YoY)
MOJO Watch
Near term sales trend is negative

Net Sales (CNY MM)

Debt-Equity Ratio
Highest at 112.43 %
in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Inventory Turnover Ratio
Lowest at 11.7 times
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Footer loading